Skip to main content
logo
Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
38.76
+1.54 (4.14%)
Aug 18, 2026, 11:35 AM EDT - Market open

Parabilis Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
1,08727.7147.28
Short-Term Investments
33.64-40.69
Cash & Short-Term Investments
1,12127.7187.98
Cash Growth
--68.50%-
Other Receivables
--1.76
Receivables
--1.76
Prepaid Expenses
4.71.652.47
Total Current Assets
1,12529.3692.21
Property, Plant & Equipment
42.4445.9452.92
Long-Term Deferred Charges
-0.6-
Other Long-Term Assets
7.434.924.13
Total Assets
1,17580.82149.25

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
18.5317.279.51
Accrued Expenses
14.3517.4112.9
Current Portion of Long-Term Debt
5.7113.082.5
Current Portion of Leases
8.267.816.88
Other Current Liabilities
5.631.220.62
Total Current Liabilities
62.8456.7932.41
Long-Term Debt
--12.79
Long-Term Leases
33.5437.8144.03
Other Long-Term Liabilities
-2.743.58
Total Liabilities
127.5397.3492.81

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Additional Paid-In Capital
1,68715.0111.66
Retained Earnings
-639.28-541.5-395.62
Comprehensive Income & Other
-0.02-0.02
Total Common Equity
1,048-526.5-383.94
Shareholders' Equity
1,048-16.5256.44
Total Liabilities & Equity
1,17580.82149.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
47.5158.766.2
Net Cash (Debt)
1,073-30.9921.78
Net Cash Growth
---
Net Cash Per Share
108.61-9.957.32
Filing Date Shares Outstanding
123.533.132.98
Total Common Shares Outstanding
123.523.132.98
Working Capital
1,063-27.4359.8
Book Value Per Share
8.48-168.09-128.98
Tangible Book Value
1,048-526.5-383.94
Tangible Book Value Per Share
8.48-168.09-128.98
Machinery
12.811.9311.91
Leasehold Improvements
4.694.564.5
SEC Filings: 10-K · 10-Q